Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Operating Income: 2010-2018

Historic Operating Income for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to -$26.3 million.

  • EyePoint Pharmaceuticals' Operating Income fell 125.67% to -$13.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$33.8 million, marking a year-over-year decrease of 94.42%. This contributed to the annual value of -$26.3 million for FY2018, which is 41.44% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Operating Income stood at -$26.3 million for FY2018, which was down 41.44% from -$18.6 million recorded in FY2017.
  • EyePoint Pharmaceuticals' 5-year Operating Income high stood at $6.4 million for FY2015, and its period low was -$26.3 million during FY2018.
  • In the last 3 years, EyePoint Pharmaceuticals' Operating Income had a median value of -$21.8 million in 2016 and averaged -$22.2 million.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Operating Income spiked by 147.60% in 2015, and later tumbled by 439.11% in 2016.
  • Over the past 5 years, EyePoint Pharmaceuticals' Operating Income (Yearly) stood at -$13.5 million in 2014, then spiked by 147.60% to $6.4 million in 2015, then slumped by 439.11% to -$21.8 million in 2016, then grew by 14.69% to -$18.6 million in 2017, then slumped by 41.44% to -$26.3 million in 2018.